Key facts
- It has raised $5.2M across 1 recorded rounds; the latest was Seed Round ($3.6M) in Jul 2024.
- Notable investors include SOSV, IndieBio, 1517 Fund, Federal Economic Development Agency for Southern Ontario, Ajira Ventures — 9 tracked in total.
- Ceragen has filed 1 Form D with the SEC, most recently Jul 2024 ($3.6M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Ceragen
Funding rounds
1 roundsAbout Ceragen
Operator of a biotechnology company intended to help increase farmer's crop yields. The company uses precision microbiome engineering through inoculant products that are tailor-made for controlled environment agriculture, enabling farmers to improve their plants' response to environmental stress.
- Sector
- Healthcare
- HQ
- Kitchener, Canada
- Founded
- 2021
- Employees
- 8
- Website
- ceragengrow.com/
- Ownership
- Privately Held (backing)
Ceragen doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ceragen shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ceragen in its N-PORT filings yet. We sweep new filings monthly.